card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Automated liquid biopsy pan-cancer genomic profiling panel demonstrates utility for screening of targeted biomarkers

Home / Insights / Automated liquid biopsy pan-cancer genomic profiling panel demonstrates utility for screening of targeted biomarkers

Advances in the analysis of circulating-free DNA (cfDNA) obtained from the plasma fraction of peripheral whole blood are facilitating minimally invasive methods to monitor health and disease. As a potential tool for the detection of cancer-specific biomarkers, liquid biopsy has considerable diagnostic and prognostic applications and has demonstrated the utility of capturing solid tumor heterogeneity and relevant actionable mutations. This analytical validation characterizes The Oncomine™ Precision Assay’s detection of hotspot mutations (substitutions, insertions, deletions, and copy number variations [CNVs]) for liquid biopsy samples. Download this poster to explore the methods, results, and conclusions of this study.

 

Complete the form below to access this scientific poster.